Skip to content
MedGenome US is now rebranded as Signios Bio – same team, renewed identity.
  • Login
  • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • RNA Sequencing
    • Immune Profiling
    • Proteomics
    • Long Read Sequencing
    • Premade Library Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Oncology Panel Sequencing
    • Epigenomics
    • Certified Service Provider
  • Multiomics Solutions
    • Academics and Research Institutes
    • Pharmaceutical and Biotechnology Companies
    • Clinical and Diagnostics Laboratories
    • Contract Research Organizations
  • Bioinformatics Solutions
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
    • FAQs
  • Company
    • About
    • News & Events
    • Grants
    • Careers
    • Contact
Signiosbio powered by medgenome
  • Sequencing Services
    • Single Cell Sequencing
    • Spatial Transcriptomics
    • RNA Sequencing
    • Immune Profiling
    • Proteomics
    • Long Read Sequencing
    • Premade Library Sequencing
    • Whole Genome Sequencing
    • Whole Exome Sequencing
    • Oncology Panel Sequencing
    • Epigenomics
    • Certified Service Provider
  • Multiomics Solutions
    • Multiomics – Academics and Research Institutes
    • Multiomics – Pharmaceutical & Biotechnology Companies
    • Multiomics – Clinical & Diagnostics Laboratories
    • Multiomics – Contract Research Organizations
  • Bioinformatics Solutions
  • Resources
    • Documents
    • Publications
    • Blog
    • Posters & Videos
  • Company
    • About
    • News & Events
    • Careers
    • Contact
  • Login

2019

First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics

March 25, 2019

Adult-Onset Myoclonus-Dystonia Syndrome Preceding Characteristic Facial Myoclonus in Indian ADCY5-related Dyskinesia

February 20, 2019

A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8(+) T-cell Responses, Impacting Tumor Challenge

January 24, 2019

Novel GNAL mutation in an Indian patient with generalized dystonia and response to deep brain stimulation

January 14, 2019

Differential methylation of the type 2 diabetes susceptibility locus KCNQ1 is associated with insulin sensitivity and is predicted by CpG site specific genetic variation

January 11, 2019
Post pagination
← Previous 1 2 3
Locations:
US:

Signios Biosciences
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

Registered Office:
MedGenome Inc. 108 West 13th Street Wilmington, Delaware 19801, County of New Castle, USA

India:
MedGenome Labs Ltd.
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100
  • Sequencing Services
  • Multiomics Solutions
  • Bioinformatics Solutions
  • Resources
  • Company
  • Login
  • Contact

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.

 

© 2026 SIGNIOSBIO. All Rights Reserved.